VIP, or Vasoactive Intestinal Peptide, is a naturally occurring signaling molecule that the body uses to help regulate inflammation and immune activity. As a therapy it is a research-stage peptide, most often given as an intranasal spray. It is not FDA approved, and at Menscape Clinic in Bangkok it would only ever be prescribed off-label and compounded by a licensed pharmacy partner under close medical supervision. The intranasal use described here is niche, the human evidence is limited and largely observational, and VIP is best understood as an experimental option discussed within a wider men's-health plan rather than a standard treatment.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Immune & Wellness
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
VIP (Vasoactive Intestinal Peptide) is a 28-amino-acid neuropeptide that occurs naturally throughout the human body, including the gut, lungs, nervous system and immune tissue. It acts as a signaling molecule, binding to receptors known as VPAC1 and VPAC2 to influence inflammation, blood flow and immune regulation. As a compounded therapy, VIP is usually supplied as an intranasal spray. It is important to be clear that VIP is a research-stage peptide: it is not an approved medicine, the human evidence for its therapeutic use is limited, and much of what is known comes from laboratory studies. At Menscape Clinic in Bangkok we present it honestly as an experimental option, not an established treatment.
/)
In the body, VIP signals through the VPAC1 and VPAC2 receptors found on immune and other cells, where it is understood to nudge the immune system toward a more regulated, less inflammatory state and to support healthy blood vessel and airway function. Researchers have studied whether supplementing VIP could help restore this signaling where it appears depleted. This is a plausible mechanism rather than a proven clinical effect. The step from how VIP behaves in the laboratory to a measurable, lasting benefit in a person has not been established by robust human trials, which is why any use is approached cautiously.
/)
Interest in intranasal VIP tends to come from men dealing with stubborn, hard-to-explain inflammatory or immune symptoms who have already worked through conventional investigation and care. It is not a first-line option and it is not for everyone. VIP is generally not appropriate for men with a history of low blood pressure, certain heart conditions, active cancer or significant allergy concerns, and it is not suitable during acute illness without specialist input. The only way to know whether VIP could even be a reasonable topic to explore is a full medical assessment with a doctor who can review your history and current medications.
/)
At Menscape Clinic in Bangkok, VIP would never be handed over as an off-the-shelf product. Any discussion starts with a consultation and appropriate testing so our doctors understand your situation and can weigh whether an experimental peptide is justified. If, and only if, it is considered clinically reasonable, VIP would be prescribed off-label and compounded by a licensed pharmacy partner, typically as an intranasal spray, with a clear protocol, monitoring and follow-up. We are an English-speaking clinic experienced with medical-tourism patients, and we will always set realistic expectations and revisit the plan based on how you respond.
/)
Every VIP (Vasoactive Intestinal Peptide) protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame VIP (Vasoactive Intestinal Peptide) as a research-stage option and prescribe only when clinically appropriate.
Native VIP is not FDA approved for any therapeutic use, and compounded intranasal VIP has not been reviewed by the FDA for safety or effectiveness. Where it is used, it is prescribed off-label and compounded by a licensed pharmacy partner under medical supervision. In Thailand, any use at Menscape Clinic in Bangkok follows local regulations and requires a doctor's prescription. We will explain its exact status to you before anything is prescribed.
The evidence is limited. The intranasal protocol best known for immune and chronic inflammation use rests largely on observational case-series data from a single clinical group, not on randomised controlled trials. Separate human trials exist for a synthetic VIP analogue in lung conditions, but those use different delivery routes and do not prove benefit for the intranasal wellness use. We treat VIP as experimental and say so openly.
VIP has been reported as generally well tolerated in the observational intranasal experience, but as an experimental, non-approved peptide its full safety profile is not established. Possible effects can include flushing, a drop in blood pressure, headache or nasal irritation, and it may not be appropriate alongside certain heart, blood-pressure or other conditions. Safety can only be judged for you individually after a doctor reviews your history and medications and provides ongoing monitoring.
VIP is studied for its role in immune regulation and in calming chronic inflammation, and a niche protocol explores intranasal VIP in chronic inflammatory response syndrome (CIRS) linked to water-damaged buildings. Being studied for something is not the same as being proven to treat it. None of these uses should be read as a guarantee of benefit, and VIP is not a cure for any condition.
In the research and compounding context discussed here, VIP is most often supplied as an intranasal spray, used on a defined schedule set by the prescribing doctor. Dosing varies and is decided case by case. We do not publish a fixed protocol online because any regimen should be individualised, supervised and adjusted over time rather than self-directed.
It is only ever considered after a full consultation and assessment, and only if our doctors judge an experimental peptide to be reasonable for your situation. If appropriate, it would be prescribed off-label and compounded by a licensed pharmacy partner with monitoring and follow-up. There is no obligation to proceed, and our team will give you a frank view of whether VIP is worth considering at all. Message us on WhatsApp under VIP to ask about an assessment.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)